Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients

• Published in: Nephrology, dialysis, transplantation Vol. 9 Suppl 3; p. 35
• Main Authors: Kokot, F, Nieszporek, T, Wiecek, A, Marcinkowski, W, Rudka, R, Trembecki, J
• Format: Journal Article
• Language: English
• Published: England 1994
• Subjects: Adult; Blood Glucose - analysis; Drug Administration Schedule; Erythropoietin - administration & dosage; Erythropoietin - therapeutic use; Gastrins - blood; Gastrins - secretion; Glucagon - blood; Hematocrit; Humans; Insulin - blood; Middle Aged; Pancreatic Hormones - secretion; Pancreatic Polypeptide - blood; Renal Dialysis; Time Factors

As already reported short-term rHuEpo treatment influences plasma insulin, glucagon, pancreatic polypeptide (PP), and gastrin secretion in haemodialysed patients. The present study aimed to assess the influence of long-term rHuEpo treatment on secretion of above mentioned hormones. A total of 27 hae...